| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner
1 company
Israel Biotech Fund I, L.P. serves as a Director, 10% Owner at ADXS. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $31.3M at current prices.
The biggest single holding is ADXS (~$31.3M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 1,317,716 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | ADXS Ayala Pharmaceuticals, Inc. | 10% Owner | Buy | 1,317,716 | $0.00 | - | -589.3% |